LINC 2018: More Data Demo IN.PACT's Impact, And Other Vasc-Device Findings

07 Feb 2018

The 2018 Leipzig Interventional Course (LINC), Jan. 30-Feb. 2, featured presentations of data from trials of peripheral stents from Biotronik and Veryan, TVA Medical's arteriovenous fistula, and drug-coated balloons from Medtronic, Boston Scientific, and Spectranetics.

view over Leipzig and its "Voelkerschlachtdenkmal" at dusk, Germany — Leipzig, Germany

The Leipzig Interventional Course is an annual four-day meeting in Leipzig, Germany featuring live cases, lectures, and poster presentations on vascular interventions to treat peripheral artery disease, carotid disease, deep vein thrombosis, aorto-iliac disease, and other non-coronary vessels. This year's meeting, held Jan. 30-Feb. 2, featured several presentations of new data from clinical trials of novel device therapies. Here are some of the highlights.

The IN.PACT SFA trial of Medtronic PLC's IN.PACT Admiral drug-coated peripheral angioplasty balloon is the first independently adjudicated,...